- Home
- ATCH vs ABVC Comparison
ATCH vs ABVC Comparison
Compare ATCH & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATCH | ABVC |
|---|---|---|
| Founded | 2022 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.6M | 34.6M |
| IPO Year | 2024 | 2009 |
Fundamental Metrics
Financial Performance| Metric | ATCH | ABVC |
|---|---|---|
| Price | $0.20 | $1.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 124.5K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.14 |
| EPS | ★ 0.05 | N/A |
| Revenue | N/A | ★ $509,589.00 |
| Revenue This Year | $84.47 | N/A |
| Revenue Next Year | $39.32 | N/A |
| P/E Ratio | $4.10 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.14 | $0.88 |
| 52 Week High | $1.92 | $4.02 |
Technical Indicators
Market Signals| Indicator | ATCH | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 44.42 | 69.68 |
| Support Level | $0.19 | $1.53 |
| Resistance Level | $0.22 | $1.71 |
| Average True Range (ATR) | 0.01 | 0.12 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 45.53 | 96.00 |
Price Performance
Historical ComparisonAbout ATCH AtlasClear Holdings Inc.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.